WSAVA Nov 2021 Proceedings - Flipbook - Page 2
Simparica Trio is approved in many countries around the world. The advertisement below reflects the indications for Canada.
HEARTWORM DISEASE
TICKS & FLEAS
ROUNDWORMS & HOOKWORMS
All this protection in
just one monthly chew
BROAD-SPECTRUM PARASITE
PROTECTION WITHOUT COMPROMISE
sarolaner/moxidectin/pyrantel
COMPREHENSIVE
COVERAGE
• Fleas, 5 tick species,
heartworm disease*,
roundworms and
hookworms
COMPLIANCE
• Expanded coverage
from a single tablet
simplifies dosing for
pet owners
CONVENIENCE
• One easy-to-give,
tasty chew for dogs from
1.3 kg up to 60 kg
• Approved for use in adult
dogs and puppies as
young as 8 weeks of age
*100% of dogs were protected in heartworm laboratory and field trials.
To prevent heartworm disease a single final dose must be given within one month after the last seasonal
exposure to mosquitoes following monthly administration during the season.
Approved labeling for registered products can be different in various countries around the world; and not all products featured in this exhibit are approved for use in every country
around the world. The information featured at the Zoetis virtual booth and promotional materials featured is based on approved labeling in US, EU, UK and/or Canada, as specifi cally
indicated on each individual product-related piece. Consult your local Zoetis representative in the country where you practice or use the ‘Contact Zoetis Form’ available in the booth
for additional product information.
Zoetis® is a registered trademark and Simparica TRIO is a trademark of Zoetis or its licensors, used under licence by Zoetis Canada Inc. MM-17044